Yang Chen, Ph.D.
Department of Translational Molecular Pathology, Division of Pathology-Lab Medicine Div
Education & Training
Degree-Granting Education
| 2014 | Tsinghua University, Beijing, CHN, PHD, Biochemistry and Molecular Biology |
| 2008 | Jilin University, Changchun, CHN, BS, Biochemistry |
Postgraduate Training
| 2014-2022 | Research Fellowship, UT MD Anderson Cancer Center, Houston, TX |
Experience & Service
Academic Appointments
Assistant Professor, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Instructor, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2022
Postdoctoral Fellow, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2021
Graduate Research Assistant, Tsinghua University, Beijing, 2010 - 2014
Teaching Assistant, Tsinghua University, Beijing, 2008 - 2010
Honors & Awards
| 2023 | Career Enhancement Program (CEP) Award of MDACC SPORE in Gastrointestinal Cancer, The University of Texas MD Anderson Cancer Center |
| 2022 | UT System Rising STARs Award, The University of Texas System |
| 2021 | Anne Eastland Spears Fellowship in Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center |
| 2021 | 1st Award Oral Competition, Annual Postdoctoral Science Symposium, The University of Texas MD Anderson Cancer Center |
| 2021 | Ergon Foundation Award, The University of Texas MD Anderson Cancer Center |
| 2020 | T32 Training Grant in Cancer Biology, The University of Texas MD Anderson Cancer Center |
| 2014 | Outstanding Graduate Students of Beijing City, Beijing People's Government |
| 2012 | National Scholarship for Outstanding Graduate Students of China, Ministry of Education of the People's Republic of China |
| 2010 | First Class Scholarship for Life Science Research, Tsinghua University |
| 2008 | Chinese Academy of Sciences (CAS) Scholarship, Chinese Academy of Sciences |
Selected Publications
Peer-Reviewed Articles
- Yang D, Moniruzzaman R, Wang H, Wang H, Chen Y. Cross-dataset single-cell analysis identifies temporal alterations in cell populations of primary pancreatic tumor and liver metastasis. Cancers 15(8):2396, 2023.
- Chen Y, Yang S, Tavormina J, Tampe D, Zeisberg M, Wang H, Mahadevan KK, Wu CJ, Sugimoto H, Chang CC, Jenq RR, McAndrews KM, Kalluri R. Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell 40(8):818-834.e9, 2022. e-Pub 2022. PMID: 35868307.
- McAndrews KM, Chen Y, Darpolor JK, Zheng X, Yang S, Carstens JL, Li B, Wang H, Miyake T, Correa de Sampaio P, Kirtley ML, Natale M, Wu CC, Sugimoto H, LeBleu VS, Kalluri R. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. Cancer Discovery 12(6):1580-1597, 2022. PMID: 35348629.
- Chen Y, Yang S, Lovisa S, Ambrose CG, McAndrews KM, Sugimoto H, Kalluri R. Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta. Nature Communications 12(1):7199, 2021. e-Pub 2021. PMID: 34893625.
- Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, LeBleu VS, McAndrews KM, Kalluri R. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J 35(5):e21557, 2021. PMID: 33855751.
- Chen Y, Kim J, Yang S, Wang H, Wu CJ, Sugimoto H, LeBleu VS, Kalluri R. Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39(4):548-565.e6, 2021. e-Pub 2021. PMID: 33667385.
- Chen Y, Keskin D, Sugimoto H, Kanasaki K, Phillips PE, Bizarro L, Sharpe A, LeBleu VS, Kalluri R. Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis. PLoS Biol 16(12):e2005907, 2018. e-Pub 2018. PMID: 30592710.
- Chen Y, LeBleu VS, Carstens JL, Sugimoto H, Zheng X, Malasi S, Saur D, Kalluri R. Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Molecular Medicine 10(10), 2018. PMID: 30120146.
- Liu G, Chen Y, Qi F, Jia L, Lu XA, He T, Fu Y, Li L, Luo Y. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling. Journal of Pathology 237(2):190-202, 2015. e-Pub 2015. PMID: 25988668.
- Wang H, Chen Y, Lu XA, Liu G, Fu Y, Luo Y. Endostatin Prevents Dietary-Induced Obesity by Inhibiting Adipogenesis and Angiogenesis. Diabetes 64(7):2442-56, 2015. e-Pub 2015. PMID: 25605807.
- Guo L, Chen Y, He T, Qi F, Liu G, Fu Y, Rao C, Wang J, Luo Y. Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis. Molecular Medicine Repports 11(5):3473-80, 2015. e-Pub 2015. PMID: 25607980.
- Chen Y, Liu G, Guo L, Wang H, Fu Y, Luo Y. Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. International Journal of Cancer 136(1):182-94, 2015. e-Pub 2014. PMID: 24798787.
- Guo L, Geng X, Chen Y, Qi F, Liu L, Miao Y, Lin Z, Yu M, Li Z, Fu Y, Li B, Luo Y. Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys. Regulatory Toxicology Pharmacology 69(3):512-23, 2014. e-Pub 2014. PMID: 24878240.
- Yang J, Song X, Chen Y, Lu XA, Fu Y, Luo Y. PLCγ1-PKCγ signaling-mediated Hsp90α plasma membrane translocation facilitates tumor metastasis. Traffic 15(8):861-78, 2014. e-Pub 2014. PMID: 24899266.
- Chen Y, DU Y, Li P, Wu F, Fu Y, Li Z, Luo Y. Phase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer. Molecular and Clinical Oncology 2(4):586-590, 2014. e-Pub 2014. PMID: 24940500.
- Zhao H, Huang Y, Xue C, Chen Y, Hou X, Guo Y, Zhao L, Hu Zh, Huang Y, Luo Y, Zhang L. Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer. PLoS One 8(1):e54674, 2013. e-Pub 2013. PMID: 23382938.
- Song N, Ding Y, Zhuo W, He T, Fu Z, Chen Y, Song X, Fu Y, Luo Y. The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. Angiogenesis 15(4):697-711, 2012. e-Pub 2012. PMID: 22711211.
- Ding Y, Song N, Liu C, He T, Zhuo W, He X, Chen Y, Song X, Fu Y, Luo Y. Heat shock cognate 70 regulates the translocation and angiogenic function of nucleolin. Arterioscler Thromb Vasc Biol 32(9):e126-34, 2012. e-Pub 2012. PMID: 22743058.
- Zhuo W, Chen Y, Song X, Luo Y. Endostatin specifically targets both tumor blood vessels and lymphatic vessels. Frontiers of Medicine 5(4):336-40, 2011. e-Pub 2011. PMID: 22198745.
- Chen Y, Wang S, Lu X, Zhang H, Fu Y, Luo Y. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood 117(23):6392-403, 2011. e-Pub 2011. PMID: 21482707.
- Fu Y, Chen Y, Luo X, Liang Y, Shi H, Gao L, Zhan S, Zhou D, Luo Y. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin. Biochemistry 48(49):11655-63, 2009. PMID: 19877579.
- Chen Y, Yang S, Fu Y, Wang J, Zhao ZJ, Fu X. Cloning and expression of intracellular part of receptor protein tyrosine phosphatase RPTP alpha and preparation of its polyclonal antibodies. Chem. Res. Chinese Universities 24(3):344-347, 2008.
- Yu Q, Chen Y, Kou C, Liu S, Yu Y. Relationship between HLA class II gene polymporphism and schizophrenia. Journal of Jilin University (Medicine Edition) 33(2):306-309, 2007.
- Zhang H, Ju G, Wei J, Hu Y, Liu L, Xu Q, Chen Y, Sun Z, Liu S, Yu Y, Guo Y, Shen Y. A combined effect of the KPNA3 and KPNB3 genes on susceptibility to schizophrenia. Neuroscience Letters 402(1-2):173-5, 2006. e-Pub 2006. PMID: 16644122.
Invited Articles
- Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nature Reviews Clinical Oncology 18(12):792-804, 2021. e-Pub 2021. PMID: 34489603.
Editorials
- McAndrews KM, Chen Y, Kalluri R. Stromal Cells Exhibit Prevalent Genetic Aberrations in Colorectal Cancer. Cancer Cell 38(6):774-775, 2020. PMID: 33321084.
Grant & Contract Support
| Title: | Functional role of an oncogenic collagen I homotrimer variant specifically produced by pancreatic cancer cells |
| Funding Source: | NIH/NCI |
| Role: | Postdoctoral Fellow |
| Title: | |
| Funding Source: | NIH/NCI |
| Role: | Postdoctoral Fellow |
| Title: | Single-cell genomics and transgenic mouse models to target collagen-responsive mechanism in pancreatic cancer |
| Funding Source: | Career Enhancement Program (CEP) Award of MDACC SPORE in Gastrointestinal Cancer |
| Role: | Principal Investigator |
| Title: | Single-cell genomics and transgenic mouse models to identify therapeutic and diagnostic targets within pancreatic tumor ecosystem |
| Funding Source: | UT Rising STARS Award |
| Role: | Principal Investigator |
| Title: | The goal for this application is to investigate the essential role of type I collagen-responsive mechanism in pancreatic tumor progression and immunosuppression |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator |
| Title: | Functional role of an oncogenic collagen I homotrimer variant specifically produced by pancreatic cancer cells The goal os this study is to study is to study the unique oncogenic Col1 homotrimers (specifically produced by cancer cells but not normal cells) that significantly promote pancreatic cancer progression and impact immune infilitration |
| Funding Source: | NIH/NCI |
| Role: | Trainee |
| Title: | Genetics and Biology of Pancreatic Ductal Adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | Postdoctoral Fellow |
Patient Reviews
CV information above last modified January 25, 2024